CONMED Corp — Director's Dealing 2019

Aug 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-08-06

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-06	Common Stock	M	12000	$39.87	Acquired	28319	Direct
2019-08-06	Common Stock	F	8598	$92.01	Disposed	19721	Direct
2019-08-06	Common Stock	M	1560	$44.90	Acquired	21281	Direct
2019-08-06	Common Stock	F	1157	$92.94	Disposed	20124	Direct
2019-08-06	Common Stock	S	2909	$92.10	Disposed	17215	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-06	Options To Purchase Common Stock	$39.87	M	12000	Disposed	2026-03-01	Common Stock (12000)	Direct
2019-08-06	Sars (Stock Appreciation Rights)	$44.90	M	1560	Disposed	2024-06-01	Common Stock (1560)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92 to $92.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.